About Purdue Pharma
Purdue Pharma is one of the largest privately owned pharmaceutical companies in the world. The company is based in Stamford, CT and employs approximately 3000 people across the U.S. It is dominated by the wealthy Sackler family who bought the company in 1952.
Purdue's Cash Cow: OxyContin
OxyContin was developed and is manufactured by Purdue Pharma. 75% of Purdue Pharma's total sales are derived from OxyContin. OxyContin garnered $25 million in sales its first year on the market in 1995 and sales last year reached $1.9 billion. According to the GAO, OxyContin is the most frequently prescribed brand name narcotic in America. OxyContin prescriptions have skyrocketed from just three hundred thousand a few years ago to more than 7 million.
Rock Bottom for Addicts, The Bottom Line For Purdue
Those who worked for Purdue say profits were pushed over medical prudence. "The company was all about the bottom dollar. Sell OxyContin. Period," Karen White, a former Purdue sales representative told ABC News last October. A former Purdue sales manager in West Virginia said that detailers were instructed to say that OxyContin was "virtually non-addictingÂ…it's not right, but that's what they told us to say."
By 1998, the company's sales force stood at 625, twice the number before Purdue produced Oxy only a few years earlier, according to the book "Pain Killer, A Wonder Drugs Trail of Addiction and Death." The company plied physicians with free trips to high-priced resort seminars in Arizona, California and Florida. The meetings had one key agenda: spread the word that pain was under-treated and doctors needed to address that vacuum by aggressively prescribing drugs like OxyContin, according to "Pain Killer."
Selling the drug was the top priority for Purdue and by last year, 75% of the company's revenues came from OxyContin. Recovering Oxy addicts like Chris Czarnocki of Royal Palm Beach, Fla., blame the drug maker for their troubles.
"They knew the side effects and still they stuck it out on the markets," said Czarnocki, who got hooked after being prescribed OxyContin following an injury. "They said it was non-addictive. They knew that if people got on it, the company would make billions of dollars. Â… It's all about money and power. How could you put that out on the street? I'd like to know what possessed them to put OxyContin on the market."
Several authorities familiar with the growing epidemic say Purdue helped fuel the drug craze through the company's aggressive and highly successful $500 million marketing campaign. U.S Rep. Edolphus Towns (D-NY) has called Oxy a scourge, while speaking on the floor of the House this month. He also said the drug company is not without blame.
http://www.oxyconned.com/index.asp